BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 2107211)

  • 21. Linear IgA bullous dermatosis with circulating IgG autoantibodies to the 230 kD epidermal antigen.
    Honoki K; Muramatsu T; Tsubakimoto A; Shirai T
    J Dermatol; 1998 Aug; 25(8):503-9. PubMed ID: 9769594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
    Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen.
    Zhu XJ; Niimi Y; Bystryn JC
    J Invest Dermatol; 1990 Jun; 94(6):817-21. PubMed ID: 1693941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoblotting studies of linear IgA disease.
    Dmochowski M; Hashimoto T; Bhogal BS; Black MM; Zone JJ; Nishikawa T
    J Dermatol Sci; 1993 Dec; 6(3):194-200. PubMed ID: 8136317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical correlations of linear IgA deposition at the cutaneous basement membrane zone.
    Peters MS; Rogers RS
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):761-70. PubMed ID: 2654216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linear dermo-epidermal IgA deposition in bullous pemphigoid.
    van Joost T; Faber WR; Westerhof W; de Mari F
    Acta Derm Venereol; 1979; 59(5):463-5. PubMed ID: 93374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural localization of binding sites of sera from patients with linear IgA bullous dermatosis.
    Kowalewski C; Haftek M; Jablonska S; Schmitt D
    Arch Dermatol Res; 1995; 287(7):636-40. PubMed ID: 8534126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of 1M NaCl split skin in the indirect immunofluorescence of the linear IgA bullous dermatoses.
    Willsteed E; Bhogal BS; Black MM; McKee P; Wojnarowska F
    J Cutan Pathol; 1990 Jun; 17(3):144-8. PubMed ID: 2197303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dermatitis herpetiformis and linear IgA bullous dermatosis.
    Smith EP; Zone JJ
    Dermatol Clin; 1993 Jul; 11(3):511-26. PubMed ID: 8365036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of sodium-chloride separated human skin in detection of circulating anti-basement membrane zone antibodies.
    Rasmussen HB; Brandrup F; Andersen J; Hagdrup H
    Acta Derm Venereol; 1989; 69(6):515-9. PubMed ID: 2575326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen specificities of antibasement membrane zone antibodies: immunofluorescence and Western immunoblotting studies.
    Muramatsu T; Shirai T; Iida T; Yamashina Y; Sakamoto K
    Arch Dermatol Res; 1988; 280(7):411-5. PubMed ID: 2462854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopathologic studies of adult linear IgA bullous dermatosis.
    Flotte TJ; Olbricht SM; Collins AB; Harrist TJ
    Arch Pathol Lab Med; 1985 May; 109(5):457-9. PubMed ID: 3885903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum from normal elderly individuals contains anti-basement membrane zone antibodies.
    Hachisuka H; Kurose K; Karashima T; Mori O; Maeyama Y
    Arch Dermatol; 1996 Oct; 132(10):1201-5. PubMed ID: 8859031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoelectronmicroscopic differentiation of linear IgA bullous dermatosis of adults with coexistence of IgA and IgG deposition from bullous pemphigoid.
    Adachi A; Tani M; Matsubayashi S; Shibata K; Horikawa T; Murata Y; Kumano K
    J Am Acad Dermatol; 1992 Sep; 27(3):394-9. PubMed ID: 1401273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.
    Sugi T; Hashimoto T; Hibi T; Nishikawa T
    J Clin Invest; 1989 Oct; 84(4):1050-5. PubMed ID: 2551921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic bullous disease of childhood and linear IgA disease of adults are IgA1-mediated diseases.
    Wojnarowska F; Bhogal BS; Black MM
    Br J Dermatol; 1994 Aug; 131(2):201-4. PubMed ID: 7917982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linear IgA bullous dermatosis induced by atorvastatin.
    König C; Eickert A; Scharfetter-Kochanek K; Krieg T; Hunzelmann N
    J Am Acad Dermatol; 2001 Apr; 44(4):689-92. PubMed ID: 11260550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of cicatricial pemphigoid or cicatricial linear IgA bullous dermatosis.
    Kumar V; Rogozinski T; Yarbrough C; Beutner EH; Chorzelski TP
    J Am Acad Dermatol; 1980 Apr; 2(4):327-31. PubMed ID: 6988474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgA anti-p200 pemphigoid.
    Wozniak K; Hashimoto T; Fukuda S; Ohyama B; Ishii N; Koga H; Dainichi T; Kowalewski C
    Arch Dermatol; 2011 Nov; 147(11):1306-10. PubMed ID: 22106117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The localization of the target antigens and antibodies in linear IgA disease is heterogeneous, and dependent on the methods used.
    Wojnarowska F; Collier PM; Allen J; Millard PR
    Br J Dermatol; 1995 May; 132(5):750-7. PubMed ID: 7772480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.